June 2026
Create an account to continue using Similarweb
View website metrics, keywords, top marketing channels, market research tools, and more.
Create your free accountasrjetsjournal.org
Global Rank
#1,327,977
159,368Showing Similarweb estimated data.
Publicly validate your site’s metrics by connecting your GA4
Reflect your success
Verify your website's traffic and engagement metrics by connecting to Google Analytics
Bounce Rate
38.57%
Pages per Visit
2.20
Avg Visit Duration
00:00:37
- Company
- - -
- Industry
- - -
Top 10 asrjetsjournal.org Competitors
The Top 10 Sites Like asrjetsjournal.org in June 2026 are ranked by their affinity to asrjetsjournal.org in terms of keyword traffic, audience targeting, and market overlap
- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
87.53%
Pages per Visit
1.64
Avg Visit Duration
00:00:08
- Company
- - -
- Industry
- - -
Global Rank
#1,214,094
621,912Bounce Rate
38.33%
Pages per Visit
1.71
Avg Visit Duration
00:00:34
Similarity Score
96%Khel Journal is a Peer Reviewed Journal. Prime Focus of the Journal is to publish articles related to the current trends of research.
- Company
- - -
- Industry
- - -
Global Rank
#1,704,828
349,136Bounce Rate
37.45%
Pages per Visit
2.64
Avg Visit Duration
00:01:39
Similarity Score
94%REA Press excels in global publishing, research, and education, promoting academic excellence and fostering worldwide knowledge exchange.
- Company
- REA Press
- Industry
- N/A
Global Rank
#1,218,428
13,844Country Rank
#64,988
21,006Category Rank
- -
Bounce Rate
39.57%
Pages per Visit
1.73
Avg Visit Duration
00:00:14
Similarity Score
90%counselling research and practice
- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
57.48%
Pages per Visit
2.05
Avg Visit Duration
00:00:16
Similarity Score
87%- Company
- - -
- Industry
- - -
Bounce Rate
33.67%
Pages per Visit
3.98
Avg Visit Duration
00:00:36
Similarity Score
83%Objective To evaluate the literature-pooled functional, anatomical and safety outcomes of aflibercept biosimilars compared with reference aflibercept for neovascular age-related macular degeneration (nAMD).Methods and analysis Systematic review and meta-analysis. Medline, Embase and CENTRAL were searched from inception to 2 June 2025. Phase 3 randomised controlled trials (RCTs) comparing aflibercept biosimilars with the reference product in patients with nAMD were included. Two independent reviewers conducted screening, data extraction, risk of bias (RoB 2) assessment and certainty of evidence assessment (Grading of Recommendations, Assessment, Development and Evaluation), with a third reviewer resolving discrepancies. Primary outcomes included mean difference (MD) change in best-corrected visual acuity (BCVA) and retinal thickness over time, risk ratio (RR) for proportion of participants gaining >15 Early Treatment Diabetic Retinopathy Study (ETDRS) letters and RR for adverse events. Meta-regression was used to evaluate the temporal stability of continuous outcomes.Results Six RCTs involving 2044 participants (1026 biosimilar, 1018 reference) were included. Five aflibercept biosimilars were evaluated, representing more than 50% of the eight biosimilars currently approved worldwide. Meta-regression revealed no significant difference in MD change in BCVA over time between biosimilar and reference aflibercept (slope: 0.0321 letters/week; p=0.1013). For MD change in retinal thickness, an initial anatomical advantage for reference aflibercept at week 0 (intercept: 9.58 µm; p=0.0449) was not sustained over time (slope: –0.1685 µm/week; p=0.2303). The pooled RR for gaining >15 ETDRS letters from baseline was 1.19 (95% CI 0.98 to 1.45; p=0.079). No statistically significant differences were observed across 15 safety outcomes.Conclusion This systematic review and meta-analysis found no statistically significant differences in functional, anatomical or safety outcomes betwee
- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
69.77%
Pages per Visit
1.43
Avg Visit Duration
00:00:42
Similarity Score
81%Cele mai frecvente întrebări despre diabetul zaharat
- Company
- - -
- Industry
- - -
Global Rank
#1,646,982
386,936Bounce Rate
76.19%
Pages per Visit
1.24
Avg Visit Duration
00:00:22
Similarity Score
77%la revista anales de química de la real sociedad española de química publica trabajos científicos originales, especializados o de revisión, de divulgación en el campo de la química que sean de calidad, actualidad e interés
- Company
- - -
- Industry
- - -
Global Rank
#1,513,754
7,736Bounce Rate
38.2%
Pages per Visit
1.73
Avg Visit Duration
00:00:45
Similarity Score
74%INTRODUZIONE Secondo il codice deontologico, l’infermiere è il professionista che pone al centro della relazione terapeutica la persona con i suoi bisogni e le sue potenzialità per garantire il benessere psicofisico dei pazienti assistiti e dei loro familiari (FNOPI, 2019). Secondo alcuni autori (Lindquist et al., 2016; Ripa & Baffi, 2004; Trail-Mahan et al., 2013; […]
- Company
- - -
- Industry
- - -
Bounce Rate
44.8%
Pages per Visit
1.60
Avg Visit Duration
00:00:06
Similarity Score
72%asrjetsjournal.org's top 5 competitors in June 2026 are: journals.covenantuniversity.edu.ng, wjpmr.com, kheljournal.com, reapress.com, and more.
According to Similarweb data of monthly visits, asrjetsjournal.org’s top competitor in June 2026 is journals.covenantuniversity.edu.ng. asrjetsjournal.org 2nd most similar site is wjpmr.com, and closing off the top 3 is kheljournal.com.
reapress.com ranks as the 4th most similar website to asrjetsjournal.org and cjc-rcc.ucalgary.ca ranks fifth in June 2026.
The other five competitors in the top 10 list are revistaveritas.org, bmjophth.bmj.com, raportuldegarda.ro, analesdequimica.es, and infermiereonline.org.